Center-Authored Papers

Filters: Author is Aapro, M S  [Clear All Filters]
2006
Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman GH, Tjan-Heijnen VC, Walewski J et al..  2006.  EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.. European journal of cancer (Oxford, England : 1990). 42(15):2433-53. Abstract
2009
von Minckwitz G, Schwenkglenks M, Skacel T, Lyman GH, Pousa LA, Bacon P, Easton V, Aapro MS.  2009.  Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis.. European journal of cancer (Oxford, England : 1990). 45(4):608-17. Abstract
2011
Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly PJ, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J et al..  2011.  2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.. European journal of cancer (Oxford, England : 1990). 47(1):8-32. Abstract